Rainbow Children Medicare
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Rainbow Children’s Medicare is poised for significant growth, driven by strategic capacity expansions and a robust pipeline of new hospital units. Management's optimistic outlook, projecting a 19% CAGR in revenue and a 21% CAGR in EBITDA over the next two years, underscores the company's commitment to enhancing its market position. However, near-term margin pressures due to increased capacity and occupancy challenges may temper overall profitability. Vista's forecast reflects an expected revenue growth acceleration beyond historical trends, supported by a stable balance sheet and a fair valuation. The healthcare sector's structural shift towards organized care and rising demand for pediatric services further bolsters this outlook. Key opportunities include the successful ramp-up of new facilities and the expansion into underpenetrated markets, while execution risks and regulatory challenges remain critical watchpoints. Overall, Rainbow Children’s Medicare is well-positioned for sustained growth, despite facing margin pressures in the short term
Why We Like This Stock
- Management projects a 19% revenue CAGR and a 21% EBITDA CAGR, indicating strong growth potential
- The company maintains a debt-free balance sheet, allowing for internal funding of expansion initiatives
- Strategic expansions into new markets and increased bed capacity are expected to enhance market share
Things To Watch Out For
- Near-term margin pressures are anticipated due to the fixed-cost burden of new hospital openings
- Execution risks related to project delays and regulatory challenges could impact growth plans
- Deteriorating foreign institutional flows may pose risks to market sentiment and investor confidence
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 1,297 | 1,516 | 1,703 | 1,929 | 2,285 |
| Profit Before Tax (Cr.) | 287 | 322 | 360 | 418 | 501 |
| PBT Margin | 22.2% | 21.2% | 2113.9% | 21.6% | 21.9% |
| Net Profit (Cr.) | 212 | 236 | 263 | 307 | 365 |
| Earnings Per Share | 20.7 | 23.2 | 25.7 | 30.0 | 35.9 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Anand Rathi | ▲ Buy | 1,750 | 04-Aug-2026 |
| Axis Securities | ▲ Buy | 1,617 | 13-Jul-2026 |
| Choice Equity | ▲ Buy | 1,650 | 03-Jun-2026 |
| HSBC | ▲ Buy | 1,400 | 21-Apr-2026 |
| IDBI Capital | ▲ Buy | 1,786 | 31-Jul-2026 |
| Moneycontrol | ▲ Overweight | nan | 15-Jun-2026 |
| Prabhudas Liladhar | ▲ Buy | 1,900 | 04-Aug-2026 |
Company Overview
Show Company Profile
Rainbow Children's Medicare Limited operates a multi-specialty paediatric, obstetrics, and gynaecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children's Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company offers women care services under Birthright brand that comprise perinatal care services, such as routine and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility support, and a range of gynecology treatments, as well as operates private pediatric DNB (Diplomate of National Board) training program offering postgraduate and fellowship opportunities to train future healthcare professionals. Rainbow Children's Medicare Limited was incorporated in 1998 and is based in Hyderabad, India.